Get the Stockscreener App
3.13
15.93%
0.43
After Hours:
3.06
-0.07
-2.24%
VolitionRX Ltd stock is traded at $3.13, with a volume of 512.61K.
It is up +15.93% in the last 24 hours and down -0.76% over the past month.
VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.
See More
Previous Close:
$2.70
Open:
$2.89
24h Volume:
512.61K
Relative Volume:
0.88
Market Cap:
$26.07M
Revenue:
$1.73M
Net Income/Loss:
$-23.50M
P/E Ratio:
-0.7165
EPS:
-4.3682
Net Cash Flow:
$-19.37M
1W Performance:
+56.50%
1M Performance:
-0.76%
6M Performance:
-51.40%
1Y Performance:
-69.72%
1-Day Range:
$2.76
$3.26
1-Week Range:
$1.906
$3.26
52-Week Range:
$1.906
$18.80
VolitionRX Ltd Stock (VNRX) Company Profile
Name
VolitionRX Ltd
Sector
Industry
Phone
646 650 1351
Address
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Compare VNRX vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
3.13 | 22.49M | 1.73M | -23.50M | -19.37M | -4.3682 |
TMO
Thermo Fisher Scientific Inc
|
448.28 | 167.00B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.00 | 122.68B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
559.37 | 43.63B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
342.37 | 33.48B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
114.96 | 32.44B | 7.07B | 1.29B | 993.00M | 4.5355 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-08-25 | Initiated | H.C. Wainwright | Buy |
| Feb-01-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-17-22 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-10-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-16-18 | Initiated | Maxim Group | Buy |
| May-14-18 | Reiterated | The Benchmark Company | Buy |
| Sep-07-16 | Reiterated | Rodman & Renshaw | Buy |
| Feb-01-16 | Initiated | Rodman & Renshaw | Buy |
View All
VolitionRX Ltd Stock (VNRX) Latest News
VolitionRx Limited (VNRX): 7 Best Rated Penny Stocks to Buy According to Wall Street Analysts - Yahoo Finance UK
VolitionRx Limited Files Form 8-K With SEC Detailing Company Information and NYSE Listing - Minichart
VolitionRx receives waiver on market capitalization covenant from Lind Global - Investing.com
VolitionRx Obtains Covenant Waiver on $9.9 Million Convertible Notes From Lind, Avoiding Acceleration - TradingView
Covenant breach leads VolitionRx (NYSE: VNRX) to secure Lind waiver and note changes - Stock Titan
VNRX Technical Analysis | Trend, Signals & Chart Patterns | VOLITIONRX LTD (NYSEARCA:VNRX) - ChartMill
VolitionRX Earnings Call: Breakthrough Science, Cash Burn Risk - TipRanks
VolitionRX Earnings Call Balances Breakthroughs and Risks - TipRanks
VolitionRx Limited (AMEX:VNRX) Q1 2026 Earnings Call Transcript - Insider Monkey
VolitionRX Ltd (VNRX) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Partnerships Propel Growth - GuruFocus
VolitionRx director Mickie Henshall to step down, board size to be reduced - Investing.com Australia
VolitionRx director Mickie Henshall to step down, board size to be reduced By Investing.com - Investing.com South Africa
Mickie Henshall to Leave Volition Board; Company to Reduce Board Size - TradingView
VolitionRx (VNRX) director exits at 2026 meeting as board shrinks to seven - Stock Titan
Lagoda holds 17.07M VolitionRX shares after amendment (VNRX) - Stock Titan
Earnings call transcript: VolitionRx Q1 2026 sees revenue surge, EPS miss - Investing.com
Full Transcript: VolitionRX Q1 2026 Earnings Call - Benzinga
Q1 2026 VolitionRX Ltd Earnings Call Transcript - GuruFocus
VolitionRx : Short Corporate Deck, May 2026 - marketscreener.com
Is VolitionRX (VNRX) a Value Trap After Q1 2026? EPS Not Disclos - GuruFocus
VolitionRX: Q1 Earnings Snapshot - marketscreener.com
VolitionRx Ltd stock (US92852X1037): Q1 2026 update and epigenetics business profile - AD HOC NEWS
Rising revenue but cash risk at VolitionRx (NYSE: VNRX) in Q1 2026 - Stock Titan
VolitionRx (NYSE: VNRX) lifts Q1 2026 revenue and secures new funding - Stock Titan
Cat cancer blood test may unlock $5M payout for VolitionRx - Stock Titan
VolitionRX Q1 2026 Earnings Call Transcript - MarketBeat
VolitionRx (VNRX) seeks approval to cut authorized shares and adopt 2026 equity plan - Stock Titan
TradingKey - TradingKey
Earnings Preview: VolitionRX to Report Financial Results Pre-market on May 15 - Moomoo
Press Release: VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update - Moomoo
What to expect from VolitionRx’s May 15 Q1 2026 earnings call - Stock Titan
MSN Money - MSN
VolitionRx (VNRX) Advances Feline Cancer Detection Research with New Submission - GuruFocus
BioMedNewsBreaks — VolitionRx Ltd. (NYSE American: VNRX) Reports High Accuracy In Feline Cancer Blood Test Study - StreetInsider
A blood test for cat lymphoma showed 86% detection at 97% specificity - Stock Titan
VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats - Financial Times
User - The Chronicle-Journal
VolitionRx Limited 2025 Annual Report: Executive Compensation, Director Ownership, and Corporate Governance Insights - Minichart
VNRX Stock Price, Quote & Chart | VOLITIONRX LTD (NYSEARCA:VNRX) - ChartMill
VolitionRX Limited (VNRX) Investment Case | Q4 2025: Earnings UnderperformEV/EBITDA - Newser
VolitionRX | 10-K/A: Annual report (Amendment) - Moomoo
CEO pay, board changes and reverse split at VolitionRx (NYSE: VNRX) - Stock Titan
VolitionRx (VNRX) Achieves Breakthrough in Sepsis Detection with New Test - GuruFocus
Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing - Barchart.com
VolitionRx Limited Announces Amendment to Certificate of Incorporation in April 2026 8-K Filing - Minichart
VolitionRx (NYSE: VNRX) implements 1-for-20 reverse stock split - Stock Titan
DISCLOSED: 5 Stocks Congress Just Bought (PC6HZG2Kcg) - Fathom Journal
Is VolitionRX Limited (VNRX) stock forming a clear pattern | Q4 2025: EPS Misses EstimatesFCF Yield - newser.com
VolitionRX | 8-K: Current report - Moomoo
Trade VNRX - Intellectia AI
VolitionRx receives NYSE American compliance plan approval By Investing.com - Investing.com Australia
VolitionRX Ltd Stock (VNRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):